A Placebo‐Controlled Trial of AQW051 in Patients With Moderate to Severe Levodopa‐Induced Dyskinesia

enthalten in: Movement disorders | 2016

von Trenkwalder, C. | Berg, D. | Rascol, O. | +30

Abnormal metabolic networks in atypical parkinsonism

enthalten in: Movement disorders | 2008

von Eckert, T. | Tang, C. | Ma, Y. | +5

Regional metabolic changes in Parkinsonian patients with normal dopaminergic imaging

enthalten in: Movement disorders | 2007

von Eckert, T. | Feigin, A. | Lewis, D. | +3

Gene transfer therapy for neurodegenerative disorders

enthalten in: Movement disorders | 2007

von Feigin, A. | Eidelberg, D.

Tc-99m ethylene cysteinate dimer SPECT in the differential diagnosis of parkinsonism

enthalten in: Movement disorders | 2002

von Feigin, A. | Antonini, A. | Fukuda, M. | +6

A Controlled Trial of Remacemide Hydrochloride in Huntington's Disease

enthalten in: Movement disorders | 1996

von Kieburtz, K. | Feigin, A. | McDermott, M. | +10

Functional Decline in Huntington's Disease

enthalten in: Movement disorders | 1995

von Feigin, A. | Kieburtz, K. | Bordwell, K. | +7